Packaging
...Samples of a drug that are selected for stability studies should be packaged in the container/clsoure system in which the drug.....It should provide an adequate seal, be compatible with the drug product, and not be a source of.....In these early stages, the IND should also indicate that appropriate stability studies with the..
http://www.fda.gov/cder/guidance/package.htm (score=100)

...FDA will maintain a requirement for reporting data from all ongoing product stability studies including.....Submit two copies of the annual progress report of postmarketing studies to the Food and Drug Administration.....A status report of each postmarketing study of the drug product concerning clinical safety..
http://www.fda.gov/OHRMS/DOCKETS/98fr/103000c.htm (score=99)

Human Drug Notes
...Where an expiration dating period is derived from stability studies conducted on the repackaged drug.....The Division of Manufacturing and Product Quality, HFD-320 Office of Compliance Center for.....396 10 HUMAN DRUG CGMP NOTES March 1996 DIVISION OF MANUFACTURING AND PRODUCT QUALITY, HFD..
http://www.fda.gov/cder/hdn/hdn396.htm (score=82)

Guidance for Industry
...ensuring that the drug product provided to the patient has the appropriate identity, strength.....provided that they meet appropriate standards or specifications as demonstrated by.....if the condition of the drug product, as a result of storage or shipping, casts doubt on the..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03d-0165-gdl0001.pdf (score=63)

MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....manufacturing, processing, packaging, controls, stability testing, or labeling operations.....conduct and/or complete prescribed studies on production batches of a drug after approval..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=47)

HUMAN DRUG CGMP NOTES June 1998
...FOR EACH BATCH OF DRUG PRODUCT, there shall be appropriate laboratory determination of.....FDA expects the validation studies will be completed in accordance with written protocols.....166, Stability testing, and 211.167, Special testing requirements; Compliance Policy Guide..
http://www.fda.gov/cder/hdn/cnotes68.htm (score=45)

Guidance on the Packaging of Test Batches
...For liquids, the total amount of bulk product packaged should be,at a minimum, 10 percent.....validation studies are conducted prior to the marketing of a drug product to assure..that.....bioequivalence study and stability studies. As an example, the number of..containers which..
http://www.fda.gov/cder/mapp/5225-1.pdf (score=44)

Guidance for Industry: Fixed Dose Combination and Co-Packaged Drug Products...
...15 Sponsors should evaluate the stability of the drug product in the actual dispensing package as well as in any.....However, drug-drug interaction studies should be conducted between the therapeutic components of the FDC or co.....Sponsors should evaluate the stability of the drug product in the actual dispensing package as well as in any..
http://www.fda.gov/oc/initiatives/hiv/hivguidance.html (score=28)

stability guidance -draft
...Stability studies for Drug for Injection products should include monitoring for appearance, clarity.....Significant change for a drug product at the accelerated stability condition and the.....include results from microbial challenge studies performed on the drug product at..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=282)

HUMAN DRUG CGMP NOTES March 1999
...176 indicates that a non-penicillin drug product must not be marketed if detectable levels of.....The CGMP regulations allow for the use of accelerated stability studies to project a tentative.....Should investigators cite firms for not conducting accelerated stability testing during..
http://www.fda.gov/cder/hdn/cnotes39.htm (score=154)

Draft Guidance for Industry Comparability Protocols Protein Drug Products...
...2 The general term product as used in this guidance means drug substance, drug product, and intermediate, or in.....In a comparability protocol we recommend that you include a plan for the stability studies that will.....CMC changes on the identity, strength, quality, purity, and potency of a specific drug product..
http://www.fda.gov/OHRMS/DOCKETS/98fr/protcmc.pdf (score=118)

Draft Guidance: ICH Q5E: Comparability of Biotechnological/Biological...
...Generally, therefore, real-time concurrent stability studies on the product potentially affected by the change.....The tests and analytical procedures chosen to define drug substance or drug product specifications alone are.....Furthermore, stability studies might be able to detect subtle differences that are not readily..
http://www.fda.gov/cber/gdlns/ichcompbio.htm (score=100)

Draft Guidance for Industry Comparability Protocols Protein Drug Products...
...2 The general term product as used in this guidance means drug substance, drug product, and intermediate, or in.....In a comparability protocol we recommend that you include a plan for the stability studies that will.....CMC changes on the identity, strength, quality, purity, and potency of a specific drug product..
http://www.fda.gov/cder/guidance/protcmc.pdf (score=100)

6003dft.doc
...therefore, real-time concurrent stability studies on the product potentially affected by.....changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....contractual arrangement to produce the intermediates, drug substance, or drug product on..
http://www.fda.gov/cder/guidance/6003dft.pdf (score=82)

International Conference on Harmonisation; Draft Guidance on Q5E...
...therefore, real-time concurrent stability studies on the product potentially affected by.....changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....contractual arrangement to produce the intermediates, drug substance, or drug product on..
http://www.fda.gov/cber/gdlns/ichcompbio.pdf (score=82)

Federal Register: August 14, 1997 (Volume 62, Number 157
...A citizen petition claiming that a particular drug product is not subject to the new drug.....Stability studies show that levothyroxine sodium exhibits a biphasic first order degradation profile.....A citizen petition that contends that a particular drug product is not subject to the new drug..
http://www.fda.gov/cder/fedreg/fr14au97-83.htm (score=64)

Q1B Photostability Testing of New Drug Substances and Products
...The extent of drug product testing should be established by assessing whether or not acceptable.....The ICH Harmonized Tripartite Guideline on Stability Testing of New Drug Substances and.....These studies, which may be undertaken in the development phase normally on the drug..
http://www.fda.gov/cder/guidance/1318.htm (score=63)

HUMAN DRUG CGMP NOTES June 1966
...used in the delivery of a medical drug product is considered an integral part of the drug.....Where stability testing reveals that the BPC is stable for the intended period of use, or.....Information on a failure of a batch of new drug product to meet a specification is required to..
http://www.fda.gov/cder/hdn/hdn696.htm (score=46)

X:TRANSFERGUIDANCEFINAL 807FN1.PDF
...have made good faith efforts to comply with the stability testing requirements but were.....The Federal Food, Drug, and Cosmetic Act requires that manufacturers establish controls.....In some cases, accelerated stability studies can be used to support tentative..expiration dates in..
http://www.fda.gov/cder/guidance/1807fn1.pdf (score=46)

Guidanc for Industry: Container and Closure Integrity Testing in Lieu of...
...testing of drugs, and provides a general indication of the information on product.....intended to provide guidance to applicants regarding the type of stability studies that.....microbial barrier, and, hence, the sterility of a drug product throughout its shelf..life..
http://www.fda.gov/cber/gdlns/contain.pdf (score=45)

Las Vegas Injury Lawyer